Key facts
- RedLeaf Biologics’s last known valuation is $14.8M (Nov 2019).
- It has raised $1.3M across 2 recorded rounds; the latest was Seed Round ($750K) in Sep 2019.
- Notable investors include Plug and Play Tech Center, US National Science Foundation, Keyhorse Capital, Feast Ventures, The Kentucky Agricultural Development Fund.
- RedLeaf Biologics has filed 4 Form Ds with the SEC since 2016, most recently Nov 2019 ($750K sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for RedLeaf Biologics
Funding rounds
2 roundsAbout RedLeaf Biologics
Producer of natural pigment products intended to offer an alternative to chemical dyes and antioxidant additives consumed in today's world. The company produces bioactive ingredients that are natural, sustainable, scalable, and socially responsible, providing clients with a safe and versatile product without compromising on quality or results.
- Sector
- Materials and Resources
- HQ
- Lexington, KY, United States
- Founded
- 2015
- Employees
- 14
- Website
- redleafbiologics.com/
- Ownership
- Privately Held (backing)
RedLeaf Biologics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RedLeaf Biologics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RedLeaf Biologics in its N-PORT filings yet. We sweep new filings monthly.